Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 3Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms, Unknown Primary 1Neoplasms 1Genetic Predisposition to Disease 1Disease 1

Interventions

Cisplatin 124Carboplatin 124Drug Therapy 118Bevacizumab 104Oxaliplatin 100Capecitabine 99Radiotherapy 96Gemcitabine 89Paclitaxel 87tislelizumab 86Cyclophosphamide 86Specimen Handling 82pembrolizumab 75toripalimab 68Magnetic Resonance Spectroscopy 65Fluorouracil 63Injections 60sintilimab 59Surgical Procedures, Operative 58Docetaxel 54anlotinib 53130-nm albumin-bound paclitaxel 49fludarabine 47Standard of Care 46Immune Checkpoint Inhibitors 45Biopsy 44Pemetrexed 43Irinotecan 43Blood Specimen Collection 43lenvatinib 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Sequence Analysis, RNA × Clear all
NCT07366008 2026-01-26

NorCUP

Haukeland University Hospital

Phase NA Not yet recruiting
350 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT04620278 2026-01-06

Genetic Investigation of Cancer Predisposition

The University of Texas Health Science Center at San Antonio

Not yet recruiting
100 enrolled

Disease, Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡